2024
Study Protocol for a Randomized Clinical Trial of Integrated eHealth for PrEP and Medications for Opioid Use Disorders for Women in the Criminal Legal System
Meyer J, Brunson S, Price C, Eaton E. Study Protocol for a Randomized Clinical Trial of Integrated eHealth for PrEP and Medications for Opioid Use Disorders for Women in the Criminal Legal System. Addiction Science and Clinical Practice: Special Issue on PrEP in People who use DrugsPeer-Reviewed Original Research In PressDecarceration to Reduce COVID-19 Infections in U.S. Immigration and Customs Enforcement Detention Facilities: A Simulation Modeling Study
Weyant C*, Meyer J*, Bromberg D, Altice F, Beyrer C, Goldhaber-Fiebart J. Decarceration to Reduce COVID-19 Infections in U.S. Immigration and Customs Enforcement Detention Facilities: A Simulation Modeling Study. Lancet Regional Health-AmericasPeer-Reviewed Original Research In PressReal-World Rollout of Injectable Antiretrovirals for HIV Prevention and Treatment: Correlates of Early Adoption
Koshy L, Payne E, Barakat L, Hao R, Sureshanand S, Cedillo Ornelas A, Dewan A, Meyer J. Real-World Rollout of Injectable Antiretrovirals for HIV Prevention and Treatment: Correlates of Early Adoption. Open Forum Infectious Diseases (OFID)Peer-Reviewed Original Research In PressFood Insecurity among Women Involved in the Criminal Legal System and Members of their Risk Network
Robles J, Kershaw T, Meyer J. Food Insecurity among Women Involved in the Criminal Legal System and Members of their Risk Network. Journal of Health Care for the Poor and Underserved, Special Issue: Research Findings on Food Access, Nutrition Security, and Health Outcomes: JHCPU 35.4Peer-Reviewed Original ResearchA PrEP decision aid for women survivors of intimate partner violence: Task-shifting implementation to domestic violence service settings
Meyer J, Lazarus E, Phillips K, Watts Z, Duroseau B, Carlson C, Price C, Kershaw T, Willie T. A PrEP decision aid for women survivors of intimate partner violence: Task-shifting implementation to domestic violence service settings. PLOS ONE 2024, 19: e0310837. PMID: 39288155, PMCID: PMC11407614, DOI: 10.1371/journal.pone.0310837.Peer-Reviewed Original ResearchConceptsIntimate partner violence survivorsIntimate partner violenceAgency staffPartner violenceHIV prevention interventionsService agenciesDomestic violence service agenciesSurvivors of intimate partner violenceWomen survivors of intimate partner violenceDomestic violence agenciesFemale IPV survivorsService delivery mechanismsHIV pre-exposure prophylaxisTrauma responseIPV survivorsPre-exposure prophylaxisPreventive health needsWomen survivorsPreventive interventionsQualitative interviewsStructural barriersAid interventionsHealth needsConsolidated Framework for Implementation ResearchAgenciesManagement of Substance Use Disorders Through Transition from Carceral to Community Settings
Ibrahim N, Altice F, Meyer J. Chapter 47, Management of Substance Use Disorders Through Transition from Carceral to Community Settings. In Jeffrey L. Metzner, Reena Kapoor, Anthony C. Tamburello III, James L. Knoll, Eds. Oxford Textbook of Correctional Psychiatry, 2nd Ed (2024).ChaptersImpact of COVID-19 on women living with HIV who are survivors of intimate partner violence
Zhang X, Price C, Pope A, Sullivan T, Meyer J. Impact of COVID-19 on women living with HIV who are survivors of intimate partner violence. BMC Public Health 2024, 24: 1352. PMID: 38769576, PMCID: PMC11103830, DOI: 10.1186/s12889-024-18862-7.Peer-Reviewed Original ResearchConceptsIntimate partner violenceIntimate partner violence exposureLifetime intimate partner violencePartner violenceRates of intimate partner violenceSurvivors of intimate partner violenceIntimate partner violence survivorsSubstance usePhysical healthMental healthImpact of COVID-19Experiences of WLWHImpact domainsHIV care engagementSubstance use problemsConcurrent mental healthIPV survivorsSample of WLWHCOVID-19-related impactsHealth emergency periodMultivariate linear regression modelPrimary explanatory variablePearson chi-square testCare engagementGroup of womenNational HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US Hospitals
Westgard L, Sato T, Bradford W, Eaton E, Pilcher F, Hale A, Singh D, Martin M, Appa A, Meyer J, Weimer M, Barakat L, Felsen U, Akiyama M, Ridgway J, Grussing E, Thakarar K, White A, Mutelayi J, Krsak M, Montague B, Nijhawan A, Balakrishnan H, Marks L, Wurcel A. National HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US Hospitals. Open Forum Infectious Diseases 2024, 11: ofae204. PMID: 38746950, PMCID: PMC11093397, DOI: 10.1093/ofid/ofae204.Peer-Reviewed Original ResearchScreening ratesHepatitis C virusTesting ratesHepatitis C virus screening ratesHIV screening ratesHIV testing ratesOpt-out testing policyHCV screening ratesStatistically significant differenceHepatitis C virus antibody testingInjection drug useAssociated with statistically significant differencesViral load testingNational HIVHospital sitesHCV antibody testingInpatient encountersUS hospitalsSignificant differenceInpatient hospitalizationU.S. hospitalsInpatient testingPWUDHospitalized peopleHospitalHIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies.
Landovitz RJ, Tao L, Yang J, de Boer M, Carter C, Das M, Baeten JM, Liu A, Hoover KW, Celum C, Grinsztejn B, Morris S, Wheeler DP, Mayer KH, Golub SA, Bekker LG, Diabaté S, Hoornenborg E, Myers J, Leech AA, McCormack S, Chan PA, Sweat M, Matthews LT, Grant R, Global F/TDF PrEP Study Team. HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies. Clin Infect Dis 2024 PMID: 38484128, DOI: 10.1093/cid/ciae143.Peer-Reviewed Original Research. Informing the Implementation of a PrEP Decision Aid in Domestic Violence Service Settings for Women Survivors of Intimate Partner Violence: A Qualitative Study.
Meyer J, Lazarus E, Phillips K, Watts ZT, Duroseau B, Carlson C, Price CR, Kershaw T, Willie TC. Informing the Implementation of a PrEP Decision Aid in Domestic Violence Service Settings for Women Survivors of Intimate Partner Violence: A Qualitative Study. PLoS ONE: Under review.Peer-Reviewed Original Research
2023
Uptake of Cervical Cancer Screening Among Female Patients Using a Mobile Medical Clinic
Degife E, Oliveira C, Znamierowski E, Meyer J, Sheth S. Uptake of Cervical Cancer Screening Among Female Patients Using a Mobile Medical Clinic. American Journal Of Preventive Medicine 2023, 65: 835-843. PMID: 37220860, PMCID: PMC10592483, DOI: 10.1016/j.amepre.2023.05.013.Peer-Reviewed Original ResearchConceptsCervical cancer screeningMobile medical clinicHealth-related social needsCervical cancerCancer screeningMedical clinicsFemale patientsCervical cancer screening uptakeCancer screening uptakeHuman papillomavirus vaccinationHigh-risk populationMultivariate logistic regressionElectronic health recordsPapillomavirus vaccinationScreening uptakePap testingRetrospective cohortPatient cohortClinic modelLower oddsPatientsUnstable housingClinicLogistic regressionCancerBuilding an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections
Gleeson S, Zapata H, Bathgate M, Emu B, Frederick J, Friedland G, Golden M, Meyer J, Radin J, Sideleau R, Shaw A, Shenoi S, Trubin P, Virata M, Barakat L, Desruisseaux M. Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections. Clinical Infectious Diseases 2023, 77: 703-710. PMID: 37078888, DOI: 10.1093/cid/ciad236.Peer-Reviewed Original ResearchConceptsEducational activitiesHealthcare inequitiesInfectious Diseases SectionSingle-center experienceCoronavirus disease 2019 (COVID-19) pandemicDisease 2019 pandemicMixed-methods assessmentLearning objectivesPilot curriculumEducational trainingCurriculumCenter experienceLong-term behavioral changesProgram outcomesDisease sectionDisease diversityPhysician perspectivesResponse rateHealth disparitiesYale SchoolInequitiesAntiracismBehavioral changesRacismEquityExperience delivering an integrated service model to people with criminal justice system involvement and housing insecurity
Baker O, Wellington C, Price C, Tracey D, Powell L, Loffredo S, Moscariello S, Meyer J. Experience delivering an integrated service model to people with criminal justice system involvement and housing insecurity. BMC Public Health 2023, 23: 222. PMID: 36732685, PMCID: PMC9892679, DOI: 10.1186/s12889-023-15108-w.Peer-Reviewed Original ResearchConceptsCriminal justice systemJustice systemService deliveryCriminal justice system involvementJustice system involvementCriminal justice involvementIntegrated service deliveryPrior felony convictionsPrison/jailHousing programsHousing insecurityHousing instabilityNeeds of peopleFelony convictionsSocial resourcesIntensity of contactJustice involvementContact encountersComprehensive needs assessmentDirect servicesSubstance use issuesHomelessnessStudy interviewsMost participantsUse issuesTolerating the Harms of Detention: With and Without COVID-19
Resnik, Judith and Meyer, Jaimie and Orihuela, Marisol, Tolerating the Harms of Detention: With and Without COVID-19. In Cohen, I., Gluck, A., Kraschel, K., & Shachar, C. (Eds.). (2023). COVID-19 and the Law: Disruption, Impact and Legacy. Cambridge: Cambridge University Press. doi:10.1017/9781009265690Chapters
2022
A PrEP Demonstration Project Using eHealth and Community Outreach to Justice-Involved Cisgender Women and Their Risk Networks
Meyer JP, Price CR, Ye Y, Qin Y, Tracey D, Demidont AC, Melbourne K, Altice FL. A PrEP Demonstration Project Using eHealth and Community Outreach to Justice-Involved Cisgender Women and Their Risk Networks. AIDS And Behavior 2022, 26: 3807-3817. PMID: 35672552, DOI: 10.1007/s10461-022-03709-2.Peer-Reviewed Original ResearchConceptsTDF/FTCPrEP care continuumPre-exposure prophylaxisPrimary care providersPrEP demonstration projectRisk network membersNon-Hispanic whitesCisgender womenOutreach modelRespondent-driven samplingPrEP awarenessCommunity outreach modelEnrolled participantsMean ageClinical criteriaIndex participantsCare continuumHIV preventionSocial comorbiditiesCare providersKey populationsPrEPSubstance useMedical insuranceWomenOverlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders
Gibson B, Hoff E, Haas A, Adams ZM, Price CR, Goddard-Eckrich D, Sheth SS, Dasgupta A, Meyer JP. Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders. Women's Health 2022, 18: 17455065211070543. PMID: 35023410, PMCID: PMC8771433, DOI: 10.1177/17455065211070543.Peer-Reviewed Original ResearchConceptsSubstance use disordersPre-exposure prophylaxisUse disordersHIV preventionReproductive healthReproductive health service utilizationHigh HIV risk behaviorHealth service utilizationUnique health issuesCross-sectional evaluationHIV risk behaviorsHigh unmet needReproductive health behaviorsReproductive health needsConcurrent clinical trialsForm of contraceptionTime of assessmentPregnancy intentionReproductive ageClinical trialsUnintended pregnancyService utilizationCriminal justice involvementDrug treatmentContraceptive use
2021
Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice
Hoff E, Rutledge R, Gibson BA, Price CR, Gallagher C, Maurer K, Meyer JP. Preexposure Prophylaxis for Women Across the Criminal Justice System: Implications for Policy and Practice. Journal Of Correctional Health Care 2021, 28: 22-31. PMID: 34762498, PMCID: PMC8825570, DOI: 10.1089/jchc.19.11.0082.Peer-Reviewed Original ResearchConceptsCriminal justice systemJustice systemHispanic/Latina ethnicityPartner violenceIncarcerated womenPrEP eligibilityPartner violence exposureViolence exposurePrEP attitudesProphylaxis implementationPreexposure prophylaxisImplementation effortsRisk perceptionLatina ethnicityMultivariate modelViolencePrEPPolicyProbationWomenEligibilityEthnicityAttitudesPracticePerceptionPreference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders
Meyer J, Price C, Tracey D, Sharpless L, Song Y, Madden L, Elwyn G, Altice F. Preference for and Efficacy of a PrEP Decision Aid for Women with Substance Use Disorders. Patient Preference And Adherence 2021, 15: 1913-1927. PMID: 34511887, PMCID: PMC8420782, DOI: 10.2147/ppa.s315543.Peer-Reviewed Original ResearchSubstance use disordersPersonal HIV riskHIV preventionAddiction treatment servicesHIV riskUse disordersTreatment servicesPatient-centered decision aidAwareness of PrEPHIV prevention cascadeInitiation of PrEPPre-exposure prophylaxisOpioid use disorderStandard of careDecision aidAlcohol use severityHalf of participantsAddiction treatment programsDA participantsPrevention cascadePrimary outcomeIndependent correlatesHigh riskDecisional preferencesHigher alcohol use severityChapter 11 HIV pre-exposure prophylaxis for people who inject drugs
Shrestha R, McCoy-Redd B, Meyer J. Chapter 11 HIV pre-exposure prophylaxis for people who inject drugs. 2021, 223-236. DOI: 10.1016/b978-0-323-68328-9.00011-4.Peer-Reviewed Original ResearchHIV preventionEffective HIV prevention toolHigh-risk sexual networksHIV pre-exposure prophylaxisLimited clinical trial dataSubstance usePre-exposure prophylaxisHIV prevention toolClinical trial dataHarm reduction programsKey target populationSubstance use disordersPart of patientsTarget populationPrEP outcomesPreexposure prophylaxisMedication adherenceHIV riskUse disordersTrial dataPWIDSexual networksPrEPPrevention toolProphylaxis
2017
Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and Prisons
Loeliger K, Altice F, Desai M, Ciarleglio M, Gallagher C, Meyer J. Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and Prisons. Open Forum Infectious Diseases 2017, 4: s38-s38. PMCID: PMC5632019, DOI: 10.1093/ofid/ofx162.092.Peer-Reviewed Original ResearchTime of linkageHIV-1 RNA testsCase managementHigher medical comorbidityPredictors of linkageViral suppression statusHIV treatment outcomesCase management dataPrior observational studiesTransitional case managementHIV careMedical comorbiditiesViral suppressionDetectable viremiaRetrospective cohortHIV outcomesRNA testIndependent correlatesPsychiatric comorbidityIncarceration periodsTreatment outcomesObservational studySuppression statusTargeted interventionsComorbidities